Search results
Dawn Allcot
Time Magazine· 5 days agoDawn Allcot is a full-time freelance writer and content marketing specialist with expertise in finance, e-commerce, technology and real estate. Her lengthy list of publishing credits includes ...
Trump: "Zelensky is the greatest salesman that's ever lived"
MSN News· 4 days agoOn 15 June, US Vice President Kamala Harris announced that the United States will provide more than...
3 Overlooked Tobacco Stocks Quietly Making Investors Rich
InvestorPlace· 1 day agoTobacco stocks have a bad reputation. Investors with a particular set of ethics tend to veer away...
Gateway - Quartz
Quartz· 4 days agoMillions of US Disney+ subscribers are getting the option to pay the same price for an ad-interrupted streaming experience, as the platform introduces a change to its subscription plans. Starting ...
"It's time for Russia to become ruthless"
MSN News· 3 days agoThe peace summit organised in Switzerland continues to provoke reactions from Russia. Dmitry Medvedev, number 5 in Putin's regime, is offended and angry....
Housing and falling mortgage rates could lift markets
TheStreet.com· 6 days agoOthers may do the work the Federal Reserve doesn't want to tackle yet as the second quarter sees its...
Worldview: Why Yoox Net-a-Porter Is Exiting China
The Business of Fashion· 4 days agoYoox Net-a-Porter is shuttering its China business. The luxury e-tailer will liquidate Fengmao, its joint venture with Chinese e-commerce giant Alibaba,...
8 Ways to Maximize Your Investments With Robo-Advisors
MediaFeed via AOL· 7 days agoIf you’re too busy to stay up-to-date on financial markets and investing strategies, one of the best...
New York Giants signing veteran running back ‘likely’ soon: 4 options including Cam Akers
MSN News· 3 days agoWith the start of training camp just a few weeks away, a new report claims the New York Giants are
CCHR Applauds FDA Panel Rejecting MDMA Psychedelic for Mental Health Treatment
Digital Journal· 5 days agoA panel of experts from the Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee has overwhelmingly rejected the use of the psychedelic MDMA, also known as Ecstasy and Molly, for post-traumatic stress disorder (PTSD), after